Active Ingredient: ETHINYL ESTRADIOL; NORETHINDRONE
Proprietary Name: NORETHIN 1/35E-21
Dosage Form; Route of Administration: TABLET; ORAL-21
Strength: 0.035MG;1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A071480
Product Number: 001
Approval Date: Apr 12, 1988
Applicant Holder Full Name: WATSON PHARMACEUTICALS INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
